Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Zohren F"" wg kryterium: Autor


Wyświetlanie 1-10 z 10
Tytuł:
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation.
Autorzy:
Schroeder T; Medical Faculty, Department of Hematology, Oncology and Clinical Immunology, University of Duesseldorf, Medical Faculty, Duesseldorf, Germany. />Czibere A
Platzbecker U
Bug G
Uharek L
Luft T
Giagounidis A
Zohren F
Bruns I
Wolschke C
Rieger K
Fenk R
Germing U
Haas R
Kröger N
Kobbe G
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2013 Jun; Vol. 27 (6), pp. 1229-35. Date of Electronic Publication: 2013 Jan 14.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Transplantation*
Salvage Therapy*
Stem Cell Transplantation*
Antimetabolites, Antineoplastic/*therapeutic use
Azacitidine/*therapeutic use
Leukemia, Myeloid, Acute/*therapy
Lymphocytes/*cytology
Myelodysplastic Syndromes/*therapy
Adult ; Aged ; Combined Modality Therapy ; Female ; Humans ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/surgery ; Male ; Middle Aged ; Myelodysplastic Syndromes/drug therapy ; Myelodysplastic Syndromes/surgery ; Recurrence ; Transplantation, Homologous
Czasopismo naukowe
Tytuł:
Ataxin1L is a regulator of HSC function highlighting the utility of cross-tissue comparisons for gene discovery.
Autorzy:
Kahle JJ; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
Souroullas GP
Yu P
Zohren F
Lee Y
Shaw CA
Zoghbi HY
Goodell MA
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2013 Mar; Vol. 9 (3), pp. e1003359. Date of Electronic Publication: 2013 Mar 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Ataxia*/genetics
Ataxia*/metabolism
Autistic Disorder*/genetics
Autistic Disorder*/metabolism
Gene Regulatory Networks*
Hematopoietic Stem Cells*/cytology
Hematopoietic Stem Cells*/metabolism
Nerve Tissue Proteins*/genetics
Nerve Tissue Proteins*/metabolism
Nuclear Proteins*/genetics
Nuclear Proteins*/metabolism
Animals ; Ataxin-1 ; Ataxins ; Brain/metabolism ; Cell Differentiation ; Cell Proliferation ; Gene Expression Regulation ; Genetic Association Studies ; Mice ; Organ Specificity ; Protein Interaction Maps
Czasopismo naukowe
Tytuł:
The transcription factor Lyl-1 regulates lymphoid specification and the maintenance of early T lineage progenitors.
Autorzy:
Zohren F; Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.
Souroullas GP
Luo M
Gerdemann U
Imperato MR
Wilson NK
Göttgens B
Lukov GL
Goodell MA
Pokaż więcej
Źródło:
Nature immunology [Nat Immunol] 2012 Jul 08; Vol. 13 (8), pp. 761-9. Date of Electronic Publication: 2012 Jul 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphopoiesis*
Basic Helix-Loop-Helix Transcription Factors/*metabolism
Lymphoid Progenitor Cells/*physiology
Neoplasm Proteins/*metabolism
T-Lymphocytes/*immunology
Animals ; Apoptosis/immunology ; Basic Helix-Loop-Helix Transcription Factors/deficiency ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Bone Marrow Cells/physiology ; CD4 Antigens/biosynthesis ; CD8 Antigens/biosynthesis ; Cell Lineage ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Lymphoid Progenitor Cells/cytology ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Neoplasm Proteins/deficiency ; Neoplasm Proteins/genetics ; T-Lymphocytes/physiology ; Thymocytes/physiology ; Transcription Factors/genetics ; Transcription Factors/metabolism
Czasopismo naukowe
Tytuł:
Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases.
Autorzy:
Zohren F; Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine-University, Düsseldorf, Germany. zohren@bcm.tmc.edu
Schroeder T
Czibere A
Fenk R
Bruns I
Kondakci M
Saure C
Haas R
Kobbe G
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2011 May; Vol. 46 (5), pp. 747-55. Date of Electronic Publication: 2010 Jul 26.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease/*prevention & control
Immunosuppressive Agents/*therapeutic use
Mycophenolic Acid/*analogs & derivatives
Tacrolimus/*administration & dosage
Adult ; Aged ; Female ; Hematologic Diseases/drug therapy ; Humans ; Male ; Middle Aged ; Mycophenolic Acid/administration & dosage ; Mycophenolic Acid/therapeutic use ; Tacrolimus/therapeutic use ; Transplantation Chimera ; Transplantation Conditioning/adverse effects ; Transplantation Conditioning/methods ; Transplantation, Homologous ; Treatment Outcome ; Vidarabine/analogs & derivatives ; Vidarabine/therapeutic use ; Whole-Body Irradiation
Czasopismo naukowe
Tytuł:
The Mexican way: a feasible approach to avoid DMSO toxicity.
Autorzy:
Schroeder T
Fenk R
Saure C
Czibere A
Bruns I
Zohren F
Haas R
Kobbe G
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2011 Mar; Vol. 46 (3), pp. 469-71. Date of Electronic Publication: 2010 Jun 14.
Typ publikacji:
Case Reports; Comment; Letter
MeSH Terms:
Dimethyl Sulfoxide*
Hematopoietic Stem Cells*
Blood Preservation/*methods
Peripheral Blood Stem Cell Transplantation/*methods
Aged ; Humans ; Male ; Mexico ; Middle Aged
Raport
Tytuł:
5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis.
Autorzy:
Czibere A; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany. />Bruns I
Kröger N
Platzbecker U
Lind J
Zohren F
Fenk R
Germing U
Schröder T
Gräf T
Haas R
Kobbe G
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2010 May; Vol. 45 (5), pp. 872-6. Date of Electronic Publication: 2009 Oct 12.
Typ publikacji:
Journal Article
MeSH Terms:
Azacitidine/*therapeutic use
Leukemia, Myeloid, Acute/*therapy
Myelodysplastic Syndromes/*therapy
Stem Cell Transplantation/*adverse effects
Adult ; Aged ; Female ; Graft vs Host Disease/complications ; Graft vs Host Disease/drug therapy ; Humans ; Male ; Middle Aged ; Recurrence ; Retrospective Studies ; Risk Factors ; Salvage Therapy ; Survival Analysis ; Transplantation, Homologous
Czasopismo naukowe
Tytuł:
Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.
Autorzy:
Zohren F; Department of Haematology, Oncology and Clinical Immunology, Heinrich Heine-University, Düsseldorf, Germany. Fabian.Zohren@med.uni-duesseldorf.de
Czibere A
Bruns I
Fenk R
Schroeder T
Gräf T
Haas R
Kobbe G
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2009 Dec; Vol. 44 (12), pp. 785-92. Date of Electronic Publication: 2009 May 11.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Transplantation Conditioning/*methods
Adolescent ; Adult ; Amsacrine/administration & dosage ; Cytarabine/administration & dosage ; Disease-Free Survival ; Follow-Up Studies ; Hematopoietic Stem Cell Transplantation ; Humans ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Recurrence ; Risk Factors ; Survival Rate ; Transplantation, Homologous ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives ; Whole-Body Irradiation/methods
Czasopismo naukowe
Tytuł:
Meningioma 1 gene is differentially expressed in CD34 positive cells from bone marrow of patients with myelodysplastic syndromes with the highest expression in refractory anemia with excess of blasts and secondary acute myeloid leukemia.
Autorzy:
Schroeder T
Czibere A
Zohren F
Aivado M
Gattermann N
Germing U
Haas R
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2009 Jun; Vol. 50 (6), pp. 1043-6.
Typ publikacji:
Letter
MeSH Terms:
Anemia/*genetics
Antigens, CD34/*blood
Bone Marrow Cells/*metabolism
Leukemia, Myeloid/*genetics
Myelodysplastic Syndromes/*genetics
Tumor Suppressor Proteins/*genetics
Acute Disease ; Adult ; Aged ; Aged, 80 and over ; Anemia/blood ; Bone Marrow Cells/pathology ; Disease Progression ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Leukemic ; Humans ; Leukemia, Myeloid/blood ; Male ; Middle Aged ; Myelodysplastic Syndromes/blood ; Retrospective Studies ; Reverse Transcriptase Polymerase Chain Reaction ; Trans-Activators
Opinia redakcyjna
Tytuł:
Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myeloma.
Autorzy:
Fenk R; Department of Haematology, Oncology and Clinical Immunology, Heinrich-Heine University, Duesseldorf, Germany. />Michael M
Zohren F
Graef T
Czibere A
Bruns I
Neumann F
Fenk B
Haas R
Kobbe G
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2007 Dec; Vol. 48 (12), pp. 2345-51.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Boronic Acids/*administration & dosage
Dexamethasone/*administration & dosage
Multiple Myeloma/*drug therapy
Nitrogen Mustard Compounds/*administration & dosage
Pyrazines/*administration & dosage
Aged ; Bendamustine Hydrochloride ; Boronic Acids/adverse effects ; Bortezomib ; Dexamethasone/adverse effects ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Multiple Myeloma/mortality ; Nitrogen Mustard Compounds/adverse effects ; Pyrazines/adverse effects ; Salvage Therapy
Czasopismo naukowe
    Wyświetlanie 1-10 z 10

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies